Alzheimer’s for Amateurs

Research Index entry · Trial

The Ozempic pill didn’t slow early Alzheimer’s in two big trials

Evidence
People · two final-stage trials
Source
doi.org
Added
19 November 2026

What it is

Semaglutide is the drug inside Ozempic, one of the GLP-1 drugs used for diabetes and weight. In two final-stage trials, evoke and evoke+, 3,808 people aged 55 to 85 with early Alzheimer’s and confirmed amyloid took a daily semaglutide pill or a placebo for two years. Memory, thinking and daily life declined at the same pace in both groups, even though a blood marker of inflammation fell. The trials raised no new safety worries.

Where it stands

  1. Lab discovery
  2. Animal studies
  3. First studies in people
  4. Large trials
  5. Approved

A clear no for slowing early Alzheimer’s. Whether GLP-1 drugs help prevent dementia before symptoms start wasn’t tested.

Update timeline

What changed

Newest first. Only changes to the subject itself appear here: new information, or something proven wrong.

  1. Watching
    The Scouts look again every Friday

    Only new information or a correction shows up here, not another mention of the same thing.

  2. Update

Research connections

Why these belong together

A connection has to say what it adds. Shared keywords alone don’t count.

Educational, not medical advice. Spot something wrong? hello@alzamateurs.com